2021
DOI: 10.3892/mco.2021.2246
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapy of extraosseous nasopharyngeal chordoma: A case report and literature review

Abstract: Chordomas are slow-growing aggressive tumors that account for 1-4% of all bone tumors. The anatomical distribution of chordomas includes 50-60% in the sacrococcygeal region, 25-30% in the skull base and 15% in the mobile spine. Virchow was the first to describe and term these tumors as ‘ecchordosis physaliphora’ in 1857, and Muller established their notochordal origin in 1895. Extraosseous chordomas of the nasopharynx are very rare, and they exhibit similarities with other lesions of the nasopharynx, presentin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 31 publications
(62 reference statements)
0
5
0
Order By: Relevance
“…3 Local recurrence with an incidence of 50-68% is common due to the aggressive nature of this tumor, and systemic metastasis to the lung, bone, liver, and lymph nodes are found in 17.8-43% of patients with chordoma. 1 Adverse prognostic factors include subtotal resection, dedifferentiated histological subtype, age >40 years, history of prior treatment, tumor size ≥4cm, gross tumor volume >25cm 3 , pharyngeal involvement, optic nerve and brain stem compression, none or low-dose radiation therapy, and female sex. 1 Surgery is the primary modality to achieve the best longterm control.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…3 Local recurrence with an incidence of 50-68% is common due to the aggressive nature of this tumor, and systemic metastasis to the lung, bone, liver, and lymph nodes are found in 17.8-43% of patients with chordoma. 1 Adverse prognostic factors include subtotal resection, dedifferentiated histological subtype, age >40 years, history of prior treatment, tumor size ≥4cm, gross tumor volume >25cm 3 , pharyngeal involvement, optic nerve and brain stem compression, none or low-dose radiation therapy, and female sex. 1 Surgery is the primary modality to achieve the best longterm control.…”
Section: Discussionmentioning
confidence: 99%
“…1 Adverse prognostic factors include subtotal resection, dedifferentiated histological subtype, age >40 years, history of prior treatment, tumor size ≥4cm, gross tumor volume >25cm 3 , pharyngeal involvement, optic nerve and brain stem compression, none or low-dose radiation therapy, and female sex. 1 Surgery is the primary modality to achieve the best longterm control.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Chordoma arising from notochordal remnants is a relatively rare malignant neoplasm that accounts for 3-4% of all primary bone tumors [1]. The anatomical distribution of chordoma consists mainly of the sacrococcygeal area (55%), the spine region (10%), and the skull area (35%) [2].…”
Section: Introductionmentioning
confidence: 99%
“…Chordomas are rare malignant bone tumors originating from embryonic remnants of the notochord and account for approximately 1-4% of all primary bone malignancies [ 1 ]. These slow-growing neoplasms predominantly affect the axial skeleton, with approximately 50-60% of tumors occurring in the sacrococcygeal region [ 2 ]. Patients with sacral chordomas often present with insidious, nonspecific symptoms caused by the compression and/or destruction of adjacent structures by the tumor [ 3 ].…”
Section: Introductionmentioning
confidence: 99%